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Lipid composition affects the biophysical properties
of membranes that provide a platform for receptor-
mediated cellular signaling. To study the regulatory
role of membrane lipid composition, we combined
genetic perturbations of sphingolipid metabolism
with the quantification of diverse steps in Toll-like
receptor (TLR) signaling and mass spectrometry-
based lipidomics. Membrane lipid composition was
broadly affected by these perturbations, revealing a
circular network of coregulated sphingolipids and
glycerophospholipids. This evolutionarily conserved
network architecture simultaneously reflected mem-
brane lipid metabolism, subcellular localization, and
adaptation mechanisms. Integration of the diverse
TLR-induced inflammatoryphenotypeswith changes
in lipid abundance assigned distinct functional roles
to individual lipid species organized across the
network. This functional annotation accurately pre-
dicted the inflammatory response of cells derived
from patients suffering from lipid storage disor-
ders, based solely on their altered membrane lipid
composition. The analytical strategy described
here empowers the understanding of higher-level
organization of membrane lipid function in diverse
biological systems.INTRODUCTION
The cellular membrane defines the minimal unit of life and cre-
ates the compartmentalization that orchestrates the transport
of molecules, intracellular signaling, cell-cell communication,
pathogen recognition, and many other processes (van Meer
et al., 2008). Membrane function is an emergent property of
the intricate interactions of its protein and lipid constituents,
with glycerophospholipids, sphingolipids, and sterols as most
abundant membrane lipids. Glycerophospholipids and sphingo-
lipids are categorized into distinct lipid classes defined by the170 Cell 162, 170–183, July 2, 2015 ª2015 The Authorschemical structure of their head group. Each lipid class contains
hundreds of different lipid species, further varying in fatty acid
chain length, linkage, and saturation, among others (Coskun
and Simons, 2011), the exact measurement of which has been
empowered by the advent of lipidomics (Shevchenko and Si-
mons, 2010; Wenk, 2005). Distinct lipid species are asymmetri-
cally distributed across the plasma membrane (PM) and the
various intracellular membranes (van Meer et al., 2008), in part
due to locally confined synthesis and active transport of lipids
(Maeda et al., 2013), providing a functionally distinct spatial
organization to the lipid landscape of a cell (Holthuis andMenon,
2014).
The plasma membrane and endosomal membranes mediate
the first line of defense in cellular innate immunity by establishing
a physical barrier against microbial pathogens and constitute the
main site of pathogen recognition by accommodating special-
ized cell surface receptors such as Toll-like receptors (TLRs).
TLRs are a conserved family of transmembrane proteins that
recognize distinct pathogen-associated molecular patterns
and activate key signaling pathways in innate immunity (Kawai
and Akira, 2010). The plasma membrane and endosomal resi-
dent TLR4, for instance, mainly recognizes gram-negative bac-
terial lipopolysaccharides (LPS), while the endosomal TLR7
and TLR9 recognize nucleic acids derived from a wide range of
microbes. TLR ligand-binding leads to receptor dimerization
and the activation of subsequent signaling cascades, which,
for most TLRs, involves a partially overlapping set of accessory
molecules (Bonham et al., 2014; Lee et al., 2012). This in turn
leads to transcriptional and metabolic changes, including the
induction and secretion of cytokines (Kawai and Akira, 2010),
as well as the upregulation of sphingolipid synthesis (Memon
et al., 1998). TLR signaling eventually triggers pathogen-specific
responses by the adaptive immune system, thus linking cellular
innate immunity to the adaptive immune system of the host (Ka-
wai and Akira, 2010). In macrophages, TLR activation induces
changes in the lipid composition and properties of cellular mem-
branes (Andreyev et al., 2010; Dennis et al., 2010), adapting the
cellular morphology for polarization and pathogen phagocytosis.
TLR signaling is meticulously regulated to clear pathogens yet
avoid host damage through hyperinflammation (Serhan et al.,
2008). Mechanisms of regulation act, among others, at the level
of transmembrane domains of TLRs, mediating dimerization and
activation (Kawai and Akira, 2010) and at the level of receptor
trafficking, altering the adaptor protein complexes and signaling
(Bonham et al., 2014; Lee et al., 2012). While selected species of
sphingolipids have been characterized in the context of inflam-
mation (Alvarez et al., 2010; Jo´zefowski et al., 2010; Vandan-
magsar et al., 2011), the chemical complexity of biological
membranes requires more global approaches to deconvolute
the function of the lipid landscape (Atilla-Gokcumen et al.,
2014; da Silveira Dos Santos et al., 2014).
RESULTS
Sphingolipid Metabolism Is Regulated by TLR
Stimulation and Modulates TLR-Induced IL-6 Release
Previously, quantitative lipidomics and genome-wide transcrip-
tional changes upon TLR4 stimulation were measured in bone
marrow-derived macrophages (BMDMs) and in the murine
macrophage RAW264.7 (RAW) cell line (Dennis et al., 2010;
Ramsey et al., 2008) (Figures S1A–S1C), which revealed sphin-
golipid metabolism to be strongly differentially regulated upon
TLR stimulation (Figure S1B). We therefore selected 24 genes
based on the sphingolipid metabolic network (Kanehisa and
Goto, 2000) focusing on ceramide metabolism, including several
poorly studied genes, all expressed in RAW cells (Figure S1D;
Table S1) (Hannun and Obeid, 2011). Their TLR4- and TLR9-
driven transcriptional regulation was measured by stimulating
RAW macrophages with LPS and unmethylated CpG DNA
(CpG), respectively (Figures 1A, S1D, and S1E).
Mapping our expression results onto the known sphingolipid
metabolic pathway showed that 18 of the 24 geneswere similarly
regulated by both TLRs (Figures 1A and S1E), consistent with the
fact that TLR4 and TLR9 activate a partially overlapping set of
downstream transcription factors (Kawai and Akira, 2010).
Genes induced by at least one TLR ligand were associated
with the de novo synthesis of ceramides (Sptlc1 and Sptlc2,
Cers5 andCers6, andOrmdl1) and their downstream processing
into other key sphingolipids including sphingomyelins (SMs) by
Sgms2, sphingosine-1-phosphate (S1P) by Sphk1, and gluco-
sylceramides (GluCers) by Ugcg (Figure 1A). In contrast, genes
involved in the degradation of sphingomyelins (Smpd1 and
related genes) and S1P (Sgpl1) were predominantly downre-
gulated (Figure 1A). This significant and consistent transcrip-
tional pattern across the network (p < 1.7 3 108; Figure S1F)
suggested increased levels of ceramides, sphingomyelins,
S1P, and glucosylceramides upon TLR stimulation, as indeed
observed in the publicly available lipidomics data (Figure S1A).
To study the roles of sphingolipids in TLR biology, we geneti-
cally perturbed these 24 genes to identify reproducible and
diverse effects on TLR signaling and quantify the corresponding
changes in membrane lipid abundance, allowing an integrated
analysis of these two cellular properties. Each of the 24 genes
and three TLR controls were targeted by three to five short
hairpin RNAs (shRNAs) in RAW macrophages resulting in 129
stable shRNA cell lines (Figure 1B; Table S1). Filtering for a
knockdown efficiency of at least 58% resulted in 87 cell lines
with a median knockdown efficiency of 88% (Figure S1G). These
87 cell lines covered the 24 genes with on average three shRNA
cell lines per gene (Table S1).In a focused screening campaign, these 87 cell lines were
monitored for differences in TLR signaling as measured by the
release of the cytokine interleukin 6 (IL-6) into the supernatant
after stimulation, a late quantitative read-out of TLR activation
(Kawai and Akira, 2010). To measure the activity of diverse
TLRs, cells were stimulated with Imiquimod (IMQ) or CpG, which
are recognized by the endosomal TLRs 7 or 9, respectively, or
with LPS, recognized by TLR4. As expected, silencing of the
TLR controls (sh:Tlr4, sh:Tlr7, sh:Tlr9) strongly attenuated their
respective ligand-induced IL-6 release compared to sh:GFP
control (Figure 1C). Silencing of genes involved in sphingolipid
metabolism led to various TLR-induced IL-6 release phenotypes
(Figure 1D). For instance, knockdown of Sphk1 or Cers2 led to
significantly reduced IL-6 release after stimulation with all three
TLR ligands, while knockdown of Ormdl1 led to enhanced IL-6
release upon endosomal TLR stimulation and decreased IL-6
release upon TLR4 stimulation (Figure 1D). Cytoplasmic recogni-
tion of pathogen-associated molecular patterns (Stetson and
Medzhitov, 2006) was not affected by silencing of Sphk1, as
stimulation with interferon stimulatory DNA or poly(dA:dT) re-
sulted in equal levels of interferon b release for sh:Sphk1 and
sh:GFP (FigureS1H). Tosummarize theTLR-induced IL-6 release
measurements over all shRNA cell lines per gene and per stim-
ulus, the log2 fold-change relative to the corresponding sh:GFP
control value was calculated and averaged over technical and
biological replicates. We next either averaged the values of
consistent and strong (absolute log2 fold-change >0.7) shRNA
phenotypes per gene (Figures 1E–1G, black dots), or, in case
these criteria were not met, the values of all shRNAs per gene
(Figures 1E–1G, gray dots). Knockdown of 18 genes affected
IL-6 release after stimulation with at least one TLR ligand consis-
tently for two or more shRNA cell lines (Figures 1E–1G), while cell
viability was unaffected in all cases. In unstimulated conditions,
the 87 shRNA cell lines showed only background IL-6 levels in
the supernatant.
In both the IMQ and CpG screens, the associated sh:Tlr7 and
sh:Tlr9 controls led to the strongest reduction in IL-6 release,
respectively (Figures 1E and 1F). In contrast, the LPS screen re-
vealed five genes whose knockdown led to an even stronger
reduction than the sh:Tlr4 control (Figure 1G). The CpG and
IMQ screens not only manifested decreased IL-6 release but
also revealed several genes which, upon knockdown, led to
increased IL-6 release after stimulation (Figures 1E and 1F).
Comparing the results of the three IL-6 release screens showed
that the CpG and IMQ screens were strongly correlated (r = 0.94)
(Figure 1H), while the LPS screen correlated considerably less
with the other two screens (mean r = 0.71). This suggested that
the sphingolipid metabolic pathway affected the endosomal
TLRs 7 and 9 to an equal extent, while TLR4 at the plasma mem-
brane was differentially affected.
Integrating the TLR-induced transcriptional regulation of
sphingolipid metabolism with the corresponding gene pertur-
bation phenotypes could reveal mechanisms by which a cell
either boosts or resolves inflammation through modulation of
its membrane lipid composition. To reveal the presence of
such mechanisms, the IL-6 screening results for all three TLR
stimuli were combined with the relative expression of target
genes in wild-type RAW cells after stimulation of TLR4 andCell 162, 170–183, July 2, 2015 ª2015 The Authors 171
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TLR9 (Figure 1I). This integration revealed a group of genes
acting to enhance pan-TLR signaling. Among those were
Ugcg and Sphk1, associated with the synthesis of the cer-
amide-derived metabolites glucosylceramides and S1P,
respectively, which were required for and induced by pan-
TLR signaling. However, the majority of the genes appeared
to dampen TLR signaling. For instance, six genes were identi-
fied as negative regulators of CpG- and IMQ-driven signaling
and transcriptionally upregulated upon TLR stimulation. Four
of these six genes encoded proteins that are associated with
de novo ceramide synthesis (Ormdl1, Sptlc1, Cers6, and
Sptlc2) (Figure 1I) and could be involved in preventing hyperin-
flammation and promoting the resolution of inflammation in
response to endosomal TLR activation (Serhan et al., 2008).
Further, a different set of genes associated with ceramide syn-
thesis was specifically regulated by and functionally involved in
TLR4 signaling (Cers5, Cers2, Smpd4, and Ormdl3) (Figure 1I).
Taken together, the integration of TLR-induced transcriptional
regulation of sphingolipid metabolic genes with their corre-
sponding perturbation phenotypes revealed both positive and
negative modulators of TLR function across various branches
of sphingolipid metabolism.
To resolve these different phenotypes at the level of indi-
vidual membrane lipids, nine gene perturbations (sh:Sptlc2_1,
sh:Cers2_4, sh:Cers6_2, sh:Smpd1_4, sh:Ormdl1_3, sh:Ugcg_1,
sh:Asah1_2, sh:Lyst_1, and sh:Cln3_1) were selected for further
characterization by quantitative lipidomics (Table S1). The IL-6
releasephenotypesuponknockdownof thesegeneswereconsis-
tent across multiple independent shRNAs (Figures 1D and S1I).
To maximize the statistical power by which lipid-phenotype rela-
tionships could be inferred, this subset of genes was chosen to
represent diverse IL-6 release phenotypes across the different
regulatory mechanisms and across sphingolipid metabolic
branches (indicated in Figures 1A, 1E–1G, and 1I).
Genetic Perturbations of Sphingolipid Metabolism Lead
to Diverse Membrane Lipid States
Mass spectrometry-based lipidomics was used to measure the
abundance of 245 membrane lipids at steady state in the nineFigure 1. TLR-Driven Transcription of the Sphingolipid Metabolic Netw
Silencing of This Network
(A) Selected sphingolipid and glycerophospholipid metabolic reactions (KEGG),
proteins (rectangles). Protein location based on KEGG where possible. Heatmap
with LPS (100 ng/ml) or CpG (5 mM) for indicated time points measured by qRT-P
are colored consistently throughout the study. Data are combined of at least tw
sphinganine; Spho, sphingosine; C1P, ceramide-1-phosphate. For other abbrev
(B) Schematic representation of the generation and characterization of stable sh
(C) IL-6 release as measured by ELISA in sh:Tlr and sh:GFP control cell lines stim
representative of at least five independent experiments and shown as mean ± S
(D) As in (C), but for sh:Sphk1, sh:Cers2, and sh:Ormdl1 cell lines. Data are repre
four technical replicates. *p < 0.005.
(E–G) Screening results of three IL-6 release screens in 87 loss-of-function cell lin
are plotted as log2 fold-change relative to the respective sh:GFP control cell line an
two or more shRNA cell lines with consistent phenotypes, while gray dots repres
lipidomics analysis. Data are combined of at least five independent experiments
(H) Scatter plot of IMQ and CpG screening results. Red line indicates linear fit. D
(I) Heatmap shows integration of target gene expression in wild-type RAW cells a
cell lines. Gray triangles indicate absence of consistent phenotypes for multiple s
See also Figure S1 and Table S1.selected cell lines and the sh:GFP control (Figure 2A). Specif-
ically, glycerophospholipids (phosphatidylcholines [PC], phos-
phatidylethanolamines [PE], phosphatidylglycerols [PG], and
phosphatidylserines [PS]) and sphingolipids (ceramides [Cer]
and sphingomyelins [SM]) were quantified. The developing field
of lipidomics still lacks standardized methods for data normali-
zation, analysis, and visualization, as well as for lipid annotation
(Snijder et al., 2014). Here, lipid levels were normalized to total
lipid content and transformed as log2 fold-change relative to
the sh:GFP control (Figure S2A). Both raw and transformed for-
mats are available as supplementary results, annotating all lipids
with two complementary nomenclatures (Table S2). The three
biological replicates displayed high reproducibility (average r =
0.89). Throughout this data set, significant increases and de-
creases were observed for the majority of lipid classes in each
of the nine perturbations, defining the unique lipid states in which
their cellular phenotypes manifested (Figure 2B).
Analysis of the changes in lipid composition caused by the
nine perturbations revealed both expected and unexpected re-
sults. As expected, in most cases silencing of an enzyme led
to increased substrate levels and/or decreased product levels.
For instance, knockdown of the serine palmitoyltransferase
Sptlc2, a key enzyme for de novo synthesis of ceramides
(Hanada, 2003), led to a strong reduction in ceramide levels
(Figure 2B). Knockdown of ceramide synthases 2 or 6 also
reduced ceramide levels, including individual species with spe-
cific fatty acid chain lengths that have previously been associ-
ated with each enzyme (Figures 2A, 2B, and S2B) (Levy and
Futerman, 2010). Total ceramide levels were decreased, and
sphingomyelin levels were increased, upon knockdown of the
sphingomyelinase Smpd1 (Figure 2B). Following this consistent
pattern, ceramide levels were significantly increased upon
knockdown of Ormdl1, a negative regulator of ceramide synthe-
sis (Breslow et al., 2010), and upon knockdown ofUgcg, the cer-
amide glucosyltransferase (Figure 2B). An unexpected reduction
in total ceramide levels was however measured upon the deple-
tion of the acid ceramidase ASAH1. This observation supports
the notion that ASAH1 may function bimodally, mediating not
just degradation but also synthesis of ceramides, consistentork and Characterization of Cytokine Release upon shRNA-Mediated
shown together with main metabolites (rounded rectangles) and 24 selected
s show relative expression of 24 selected genes after stimulation of RAW cells
CR. Bold protein names indicate selection for lipidomics analysis. Metabolites
o independent experiments with technical triplicates. FC, fold-change; Spha,
iations, see text or legend and Table S1.
RNA RAW cell lines, filtered based on knockdown efficiency.
ulated with IMQ (5 mM), or LPS (100 ng/ml) or CpG (5 mM) for 16 hr. Data are
D of four technical replicates. *p < 0.0001.
sentative of at least five independent experiments and shown as mean ± SD of
es stimulated for 16 hr with IMQ, CpG, and LPS as measured by ELISA. Values
d averaged overmultiple shRNA cell lines. Black dots represent the averages of
ent averages of all shRNA cell lines per gene. Indicated genes are selected for
.
ata are combined of at least five independent experiments.
fter stimulation with LPS and CpG and IL-6 release screening results of shRNA
hRNAs per gene. Data are combined of at least five independent experiments.
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Figure 2. Quantitative Lipidomics of Nine Stable shRNA Cell Lines Targeting Sphingolipid Metabolism Reveals Strongly Altered Lipid States
(A) Lipidomics analysis of nine loss-of-function cell lines. Values are shown as log2 fold-change relative to sh:GFP. Each dot represents a lipid species, color
coded per lipid class. Dot size indicates significance. Lipidomics data are combined of three independent experiments and represented as mean.
(B) Hierarchical clustering of average log2 fold-change lipid levels per lipid class and cell line. Lipidomics data are combined of three independent experiments
and represented as mean. *p < 0.05.
See also Figure S2 and Table S2.with previous in vitro data (Okino et al., 2003) (Figure 2B). Given
that most of these perturbed genes are members of larger
conserved gene families, based on either sequence similarity
or enzymatic function, the strongly altered lipid states revealed
an absence of redundancy between these family members.
This goes against previous findings suggesting functional redun-
dancy within the ORM1-like gene family (Siow and Wattenberg,
2012).
Perturbing sphingolipid metabolism unexpectedly led to
changes in glycerophospholipid levels, with strongest changes
observed upon knockdown of Sptlc2 and Ormdl1 (Figure 2B).
Knockdown of Lyst and Cln3, both involved in lysosomal
trafficking, only led to significantly altered glycerophospholipid
levels (Figure 2B). In summary, the selected set of genetic per-
turbations targeting sphingolipid metabolism translated to a
remarkable heterogeneity in lipid states, revealing considerable
tolerance of cells to such perturbations and establishing these
as an effective method to alter cellular lipid composition and
study the functional consequences. Additionally, this membrane
lipidomics analysis underscored a strong link between the sphin-
golipid and glycerophospholipid metabolic networks.
Hierarchical clustering of the average fold-changes per lipid
class and per cell line separated genes associatedwith ceramide
synthesis from those associated with other processes (Fig-
ure 2B). We therefore applied the hierarchical interaction score
(HIS) for network reconstruction between perturbed genes174 Cell 162, 170–183, July 2, 2015 ª2015 The Authors(Snijder et al., 2013), analyzing hierarchical patterns among the
measured lipid species of each perturbation (Figure S2C). The
HIS correctly inferred the known metabolic hierarchy of the
different enzymes starting with SPTLC2, over CERS2 and
CERS6, to ASAH1 and SMPD1 (Figure S2C). This intriguingly
suggested that diverse membrane lipid states resulting from
genetic perturbations may be instrumental for the unbiased
reconstruction of gene-centered metabolic networks, as also
shown in yeast (da Silveira Dos Santos et al., 2014).
A Logical Circular Network of Coregulated Lipids
Given the broad changes in lipid composition over the diverse
genetic perturbations, we next analyzed the coregulation of lipid
abundance at the level of individual lipid species to expose the
larger organizational principles that orchestrate membrane lipid
composition. Comparing the lipid abundance of individual lipid
species across all nine perturbations revealed pairs of positively
and negatively correlated lipids (Figure 3A). Such positive corre-
lations, indicative of lipid coregulation, occurred both within and
between lipid classes (Figure 3B). Hierarchical clustering of the
complete lipid-lipid correlation matrix describing 29,890 unique
pairs of lipids revealed ten distinct lipid clusters of positively
correlated lipids, organized along the diagonal of the matrix
(Figure 3C). Neighboring clusters showed positive correlations,
whereas distant clusters were negatively correlated with each
other (Figure 3C). Intriguingly, analysis of the lipid composition
per cluster revealed sphingolipids to be distributed over all
clusters, whereas significant separation of glycerophospholipid
classes was observed between different clusters (Figure 3D).
Positively correlated glycerophospholipid classes reflected their
proximity in the metabolic pathway, as clusters 8 and 9, the two
largest clusters, contained most PS and PE species, and clus-
ters 1 to 5 grouped most PC and PG species. Interestingly, the
strong negative correlation between these two sets of clusters
identified that a loss in PS and PEwas associated with increased
levels of PC, as observed for sh:Sptlc2 and sh:Ormdl1 and
inversely for sh:Cln3 (Figure 2B). This general trend has also
been reported in yeast and may be indicative of conserved
metabolic adaptation (Boumann et al., 2006). Positive correla-
tions therefore indicated coregulation between lipids driven by
proximity in metabolic pathways and structural dependencies.
Negative correlations, in turn, reflected compensation or adapta-
tion between lipids within the cell. Analysis of fatty acid chain
length properties per cluster and lipid class further revealed
that separation of lipid species from the same class into different
clusters was associated with significant changes in chain length,
following a trend over neighboring clusters (p < 0.01 – p < 0.001,
Figure 3E).
Interestingly, the most distant lipid clusters 1 and 10 were
positively correlated, which suggested that this hierarchical
view on cluster organization was a suboptimal representation
of lipid coregulation (Figure 3C). We therefore transformed the
lipid-lipid correlation matrix into a network where nodes repre-
sented individual lipid species and edges represented positive
correlations of 0.7 or higher (Figure 3F). Strikingly, this correlation
network displayed near-perfect circularity. Continuity across the
different lipid clusters was revealed by mapping different lipid
features, including lipid class, and fatty acid linkage and chain
length, onto the network (Figures 3F, S3A, and S3B). This
network view furthermore emphasized the distribution of sphin-
gomyelins and, to a lesser extent, ceramides across the network,
indicative of a general strong coregulation of individual sphingo-
lipids with glycerophospholipids (Figure 3F).
Color-coding each node in this network according to the log2
fold-change in lipid abundance revealed significant (p < 3.6 3
1028) bimodal separation of increased and decreased lipids
for each of the nine perturbations (Figure 3G). These bimodalities
reflected an imbalance in the lipid state of each perturbation,
supporting the notion that opposite segments of the circular
network were also defined by metabolic adaptation. Validating
the relevance of this circular network beyond this dataset, the
results of an independently performed lipidomics analysis in
RAW cells stably silencing Smpdl3b were projected on this
network, which also led to the significant separation of increased
and decreased lipids (p < 1.2 3 105), revealing yet another
unique lipid state (Figure S3C) (Heinz et al., 2015).
Cellular membranes are known to be comprised of lipids with
similar fatty acid chain lengths (Holthuis and Menon, 2014; van
Meer et al., 2008). Indeed, themajority (58%) of lipid coregulation
was found between lipid species with fatty acid chain length
differences of two or less, with only ceramides not following
this trend (Figure 3H). To assess if the circular network reflected
the spatial organization of lipids, we used publicly available lipi-
domics measurements of subcellular membrane fractions ofRAW cells (Andreyev et al., 2010). Mapping of lipids enriched
in the different fractions identified distinct segments of the circu-
lar network predominantly connecting lipids enriched in either
plasma membrane (PM; p < 7.3 3 106) or ER (p < 0.00022)
fractions (Figure 3I). Consistent with previous reports, the core-
gulated long-chained PS and PE species were mostly enriched
in the plasma membrane fraction, while the PC species were
mostly ER-enriched (Figure 3I) (van Meer et al., 2008). Calcu-
lating the significance of the clustering of enriched lipids on
the circular network further revealed significant clustering of
nuclear-enriched lipids (p < 4.3 3 106), but not of mitochon-
drial-enriched lipids (Figure 3I).
As an alternative to a protein-centered view on metabolic net-
works, this analysis of lipid coregulation offered a unique view of
the mammalian lipid landscape, revealing a potentially universal
logic in lipid organization. Intriguingly, circularity is not typically
observed in biological coregulation networks (Costanzo et al.,
2010) and may therefore be a unique property of metabolic
networks.
Functional Annotation of the Lipid Landscape in TLR
Signaling
We next sought to resolve the diverse TLR-phenotypes at the
level of earlier TLR signaling and integrate the phenotypes with
the abundance of individual lipid species. IL-6 release into the
supernatant is a late read-out of TLR activation, as it depends
on TLR expression, trafficking, signaling, and cytokine transcrip-
tion. Therefore, TLR4 plasma membrane levels at steady state
as well as LPS-induced internalization dynamics over time (Fig-
ure S4A) were monitored for all 24 genetic perturbations and
controls using representative cell lines (Figure 4A; Table S1).
Silencing of eight genes showed significant reductions of TLR4
surface levels at steady state (>40% reduction at p < 0.01)
although none of the genetic perturbations led to a reduction
stronger than sh:Tlr4 (87.5%) (Figures S4B–S4D). LPS-depen-
dent activation of TLR4 led to partial receptor internalization at
5 min and a near complete internalization after 30 min for all
monitored perturbations (Figures 4A, S4C, and S4D). Normal
TLR4 surface levels at steady state were observed for most of
the genetic perturbations that led to the strongest reductions in
LPS-induced IL-6 release (Figure S4E). However, increased
internalization of the receptor 5 min post-stimulation was
observed for several perturbations including the three that led
to the strongest reductions in IL-6 release (Cers2, Cers5,
Ormdl2). Sphingolipid metabolism therefore mostly modulated
LPS-induced IL-6 release by altering the trafficking and likely
subsequent signaling of TLR4 after stimulation rather than by
altering the steady-state TLR4 surface levels.
To monitor changes in early TLR signaling we performed time
coursemeasurements of TLR-induced Il6 transcription for a sub-
set of genetic perturbations including the nine cell lines analyzed
by lipidomics (Table S1). Strong changes in Il6 transcript levels
were observed, while peak Il6 transcript levels were maintained
at 10 hr post-stimulation for all tested cell lines (Figures 4B and
S4F), indicating that sphingolipid metabolism affected early
TLR signaling, modulating the amplitude not the dynamics of
TLR-induced Il6 transcription. Integration with the correspond-
ing IL-6 release phenotypes could separate changes in TLRCell 162, 170–183, July 2, 2015 ª2015 The Authors 175
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signaling from defects in cytokine secretion. As expected, most
of the cell lines tested displayed altered Il6 transcription
coherentwith themeasured changes in IL-6 release (Figure S4G).
Surprisingly though, knockdown of Cers2 showed increased
Il6 transcription but decreased IL-6 release, suggestive of
enhanced TLR signaling being followed by a post-transcriptional
block, potentially at the level of secretion (Figures S4F and S4G).
Indeed, intracellular staining of IL-6 after stimulation revealed a
strong perinuclear accumulation in a subset of Cers2 silenced
cells, while no intracellular accumulation was observed in the
controls (sh:GFP or sh:Tlr4) (Figure S4H). Knockdown of Cers2
did however not affect the regulated exocytosis of chemokine
CCL5 (Lacy and Stow, 2011), as its TLR-induced release was
not reduced (Figure S4I).
Integration of TLR-dependent read-outs with the changes in
lipid abundance could allow functional annotation of individual
lipids across the lipid landscape. To identify the changes of lipid
abundance associated with, for instance, TLR4 surface levels,
we analyzed consistent trends over all nine perturbations. This
correlation analysis revealed potential functional relationships,
as exemplified by the negative correlation (r = 0.84) between
the relative abundance of ceramide C20:0 and TLR4 PM levels
(Figure 4C). An increase of this lipid species, strongest in
sh:Ormdl1 and sh:Ugcg, was associated with reduced TLR4
levels at the plasma membrane (Figure 4D). However, the strong
coregulation in the abundance of lipid species identified in this
study necessitated a more global analysis of potential lipid func-
tion. Therefore, correlations between each TLR-related process
and the relative abundance of each lipid were calculated (n =
2,205; Table S2) andmapped onto the lipid coregulatory network
(Figures 4E–4H). This resulted in highly significant (p < 3.1 3
1063) separations of positive and negative correlations between
functional readouts and lipid abundance (Figures 4E–4H and
S4J). Comparing the functional annotations for TLR4 PM levels
with Il6 transcription and IL-6 release revealed different yet over-
lapping segments of the circular network to be positively and
negatively correlated (Figure 4E–4H). This suggested thatFigure 3. Analysis of Lipid Abundance Reveals the Circular Organizati
(A) Scatter plots show example pairs of lipids whose relative abundance over the
Red lines indicate linear fit. Data are combined of three independent experiment
(B) Analysis of the fraction of correlations that link lipids of the same lipid class (wh
combined of three independent experiments and shown as mean.
(C) Hierarchical clustering of the lipid-lipid correlation matrix. Rows and columns c
strongly positively correlated lipids. Lipid cluster numbers indicated on the right.
(D) Analysis of the number of lipids in each cluster per lipid class. Width of the bar
and shown as mean.
(E) Normalized fatty acid chain lengths for selected clusters and lipid classes. Lip
the longest fatty acid side chain per class. Data are combined of three independ
(F) Network visualization of the positive lipid-lipid correlations. Edges are correlat
acid bonds, chain length, and lysolipids, respectively (see legends). Data are com
(G) Nodes of the network are color-coded based on the fold-change of relative lip
are combined of three independent experiments and shown as mean.
(H) Cumulative percentage of lipid coregulation as a function of the maximum fat
combined of three independent experiments and shown as mean.
(I) Left: network visualization of lipid enrichment in either ER (blue) or plasmamem
measured lipids. Right: significance of the clustering on the circular network fo
absolute difference between enrichment scores of direct neighbors in the network
Subcellular fraction data are from http://lipidmaps.org combined of three indepe
See also Figure S3.distinct sets of lipids were functionally related to each step in
TLR signaling. The distribution of the functional annotations on
the network did not considerably change depending on the
different ligands for TLR-induced IL-6 release or time points for
LPS-induced TLR4 surface levels, despite changes at the indi-
vidual lipid level (Figures 4E–4H and S4J).
The similarity in predicted lipid function of neighboring and
coregulated lipids in the lipid landscape is consistent with the
view that the majority of membrane lipids function in concert
with other lipids. Mapping the different correlations onto the cir-
cular lipid network revealed short-chained glycerophospholipids
and sphingomyelins as positively associated with TLR4 surface
expression (Figures 4E and 3F). The majority of ceramides
were predicted to negatively modulate TLR4 surface expression,
similar to studies reporting that accumulation of ceramides at the
plasma membrane led to altered surface expression of the nico-
tinic acetylcholine receptor (Gallegos et al., 2008). Among the
other lipids negatively correlated with TLR4 PM levels were the
glycerophospholipids with the longest fatty acid chains associ-
ated with the plasma membrane, as well as their lysolipids (Fig-
ure 4E). Lysolipids facilitate membrane curvature required for
vesicle trafficking (Holthuis and Menon, 2014). The subset of
lipids negatively correlated with both IL-6 release and TLR4
PM levels contained most PS species (Figures 4E, 4G, and
4H), for which individual species have been described to nega-
tively influence TLR-induced responses by disruptingmembrane
microdomains (Parker et al., 2008). Intriguingly, sphingomyelins
and ceramides were predicted to both positively and negatively
regulate IL-6 release: unsaturated sphingomyelins and short-
chained ceramides resided within the positively correlated
region of the network, while saturated or nearly saturated sphin-
gomyelins and long-chained ceramides resided within the nega-
tively correlated region at the opposite segment of the network
(Figures 4G, 4H, and S4K).
To validate the different predicted functions of sphingolipids in
TLR-induced IL-6 release, candidate lipids were selected from
the coregulated lipid clusters most enriched for either positiveon of the Lipid Coregulatory Network
nine perturbations is negatively (left panel) or positively (right panel) correlated.
s and shown as mean.
ite) or different lipid classes (gray), as function of correlation strength. Data are
orrespond to the 245 measured lipid species. Black boxes indicate clusters of
Data are combined of three independent experiments and shown as mean.
s is scaled to match (C). Data are combined of three independent experiments
id classes are colored as in (D). Chain length is normalized from the shortest to
ent experiments and shown as mean. Values are mean ± SEM.
ions of rR 0.7. Nodes are lipids. Node shape, size, and outline represent fatty
bined of three independent experiments and shown as mean.
id abundance for each of the nine shRNA cell lines as indicated in legend. Data
ty acid chain length difference per lipid class and for all (see legend). Data are
brane (PM, green) subcellular fractions. White nodes depict not enriched or not
r the enrichment in four subcellular fractions. Red lines indicate the average
, gray areas indicate the distribution of randomized repeats. NS, not significant.
ndent experiments and shown as mean.
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Figure 4. Inference and Validation of Lipid Function in TLR-Related Processes
(A) TLR4 PM levels after stimulation with LPS for indicated time points normalized to unstained and steady-state control levels for 41 cell lines silencing 24 genes.
Both box-and-whisker plots and individual line plots are shown. Lines represent mean values of two independent experiments.
(B) Il6 expression after TLR stimulationmeasured at indicated time points and normalized to unstimulated and 10h sh:GFP control for 14 cell lines. Lines represent
mean values of two independent experiments.
(C) Scatter plot shows example correlation between relative lipid abundance and TLR4 PM levels over the nine perturbations. Red line indicates linear fit.
(D) As in (A), TLR4 PM levels for sh:Ormdl1_3, sh:Ormdl1_4 and sh:GFP control. Data are shown as mean ± SD of two technical replicates *p < 0.05.
(E–H) Correlations between relative lipid abundance and measurements of selected TLR-related processes plotted on the circular network.
(I and J) Network close-up of lipids positively (I) and negatively (J) correlated with LPS-induced IL-6 release.
(legend continued on next page)
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or negative correlations (Figures 4I–4L). A determining factor in
candidate selection was the availability of synthetic lipids in a
chemically pure form. Compared to vehicle treatment, RAW
macrophages showed enhanced LPS-stimulated IL-6 release
when pre-treated with the ceramides N-C18:0(OH)-Cer or
N-C8:0(2H)-Cer (Figure 4M), validating the inferred function of
these two ceramides. Treatment with these lipids alone did not
induce IL-6 release. Conversely, LPS-induced IL-6 release after
pre-treatment with the sphingomyelin SM C24:0 or the ceramide
N-C16:0-Cer was dampened compared to vehicle treatment
(Figure 4N), validating the inferred inhibitory function of these
lipids on IL-6 release. Lipid supplementation did not affect
viability in any of the experiments (Figure S4L).
As sh:Smpdl3b was not included in the set of perturbations
that led to the identification of the lipid coregulatory network
and to the lipid functional annotations, the lipidomics analysis
of sh:Smpdl3b, performed with different infrastructure, was
used to test the predictive power of the complete functional
annotation of the lipid landscape (Figure S4M). The lipid state
of sh:Smpdl3b displayed a highly significant increase of lipids
positively associated with, and a decrease of lipids negatively
associated with LPS-induced IL-6 release (p < 2.4 3 108).
This, therefore, correctly predicted a TLR-induced hyperinflam-
matory phenotype upon knockdown of Smpdl3b in the same
cellular system, based solely on the changes in lipid abundance.
Validation experiments confirmed increased pan-TLR signaling
in Smpdl3b knockdown cells, and Smpdl3b knockout mice
displayed enhanced inflammation in LPS- and Escherichia coli-
induced peritonitis models (Heinz et al., 2015). Further, pre-treat-
ment of the hyperinflammatory sh:Smpdl3b cells with a set of
ceramide lipid species here predicted to act anti-inflammatory
lowered LPS-induced IL-6 release to the levels observed in
sh:GFP control (Heinz et al., 2015).
In conclusion, organization of the lipid coregulatory network
strongly reflected lipid function across the diverse steps of TLR
signaling, revealing a higher-level functional organization for
membrane lipids with predictive power at the level of single lipids
and the global lipid landscape.
The Lipid Coregulatory Network Is Conserved between
Human and Mouse
Mutations in genes associated with sphingolipid metabolism
lead to sphingolipid storage disorders associated with severe
neurodegeneration and premature death (Futerman and van
Meer, 2004). In both patients and mouse models of these dis-
eases, altered cytokine levels have been reported previously
(Barak et al., 1999; Wang et al., 2014). To test the validity of
the functional annotation of the lipid landscape in a human
setting, and independent of shRNA-mediated gene silencing,
we performed quantitative lipidomics on patient-derived fibro-(K) Example correlation of the relative abundance of N-C18:0(OH)-Cer with LPS-
(L) As in (K), but for the negatively correlated N-C16:0-Cer.
(M) IL-6 release as measured by ELISA after pre-treatment with N-C18:0(OH)-C
representative of three independent experiments and presented as mean ± SD o
(N) As in (M), pre-treatment with N-C16:0-Cer (15 mM) or SM C24:0 (15 mM) or
periments and presented as mean ± SD of four technical replicates. *p < 0.005.
See also Figure S4 and Table S1.blasts and their age-matched healthy controls at steady state
(Table S3). The patient fibroblasts harbored mutations associ-
ated with Gaucher disease, Krabbe disease, Farber disease,
and Chediak-Higashi syndrome (Figure 5A). Calculation of the
fold-changes of membrane lipid abundance by normalizing
against the corresponding healthy controls showed that the fi-
broblasts also displayed broadly altered lipid states, affecting
both glycerophospholipids and sphingolipids (Figure S5A).
Measuring lipid-lipid coregulation in this smaller dataset derived
from human fibroblasts significantly confirmed the circular lipid
coregulatory network derived from mouse RAW macrophages
(p < 10222, Figure 5B). This striking overlap showed conserva-
tion of the circular organization of lipid coregulation across
species, cell types, and genetic perturbations. Plotting the
fold-change lipid abundance for each disease onto the circular
network further confirmed the bimodal separation of increased
and decreased lipids, indicating that the adaptationmechanisms
revealed by the circular organization also occurred in human
cells (Figure 5C).
Lipid Functional Annotation Predicts the TLR-Induced
Response of Patient-Derived Fibroblasts
To globally test the validity of the functional lipid annotations, we
next used the changes in lipid abundance to predict the inflam-
matory states of the patient fibroblasts. The lipid states of
Krabbe and Gaucher patient-derived fibroblasts displayed
strong positive correlations with the functional lipid annotations
for IL-6 release, predictive of a hyperinflammatory response (Fig-
ure 5D). Inversely, the lipid states of Farber and Chediak-Higashi
patient-derived fibroblasts were predictive of a dampened cyto-
kine release in response to LPS and CpG (Figure 5D). Strikingly,
TLR stimulation of the four patient fibroblast samples and corre-
sponding healthy control samples confirmed the predicted in-
flammatory states; with increased IL-6 release measured for
Krabbe and Gaucher and decreased IL-6 release measured for
Farber and Chediak-Higashi fibroblasts (Figure 5E). In unstimu-
lated conditions, all of the human samples showed only back-
ground IL-6 levels in the supernatant (Figure 5E). When calcu-
lating the log2 fold-changes in lipid abundance between pairs
of healthy controls, the resulting lipid states were not predictive
of either a hyperinflammatory or dampened inflammatory
response (Figures 5F and S5B). Indeed, when stimulated under
equal conditions, no significant differences in TLR-induced IL-
6 release weremeasured between the healthy control fibroblasts
(Figure S5C). In total, the functional lipid annotation derived from
RAW cells correctly predicted the inflammatory state of seven of
the eight different human fibroblast samples (Figure 5F). The lipid
state of the second Gaucher patient fibroblast sample was
significantly clustered on the circular network of lipid coregula-
tion (Figure S5D), but was not predictive of an altered IL-6induced IL-6 release over all nine cell lines. Red line indicates linear fit.
er (15mM) or N-C8:0-Cer(2H) (15 mM) or respective vehicle controls. Data are
f four technical replicates. *p < 0.005.
respective vehicle controls. Data are representative of three independent ex-
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Figure 5. Lipidomics Analysis of Patient-Derived Fibroblasts Confirms the Circular Lipid Coregulatory Network and Functional Lipid
Annotations
(A) Overview of different patient-derived fibroblast samples. Mutated genes are indicated in a close-up of the ceramide metabolic network.
(B) Coregulated lipids observed in both datasets (see legend). Significance (p < 10222) calculated by the hypergeometric distribution. Data are combined of three
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(legend continued on next page)
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release phenotype (Figure S5E), even though this was experi-
mentally shown (Figure S5F). Taken together, quantitative lip-
idomics of patient-derived fibroblasts confirmed both the lipid
coregulatory network and the functional annotation of lipids in
TLR-induced IL-6 release.
DISCUSSION
Building on the previous success of network-informed perturba-
tion strategies (Bouwmeester et al., 2004) and the ability to
quantitatively measure lipid abundance of hundreds of lipid
species (Shevchenko and Simons, 2010; Wenk, 2005), we
have developed an integrative framework that combined quanti-
tative lipidomics with genetic perturbations and their phenotypic
assessment across various TLR-related parameters. In analogy
to the early advances in transcriptomics (Eisen et al., 1998),
our approach led to the discovery of the conserved circular orga-
nization of lipid coregulation and the unbiased inference of lipid
function in innate immunity across the lipid landscape.
As the circular lipid network reflects the intersection of
different lipid metabolic pathways, metabolic adaptability, and
the spatial organization of lipids, it offers a global view of the
mammalian lipid landscape. Metabolic pathways commonly
display circular motifs, with the citric acid cycle and the urea
cycle as well-known examples. Circularity in metabolite coregu-
lation at the order of magnitude discovered here may therefore
be a fundamental property of lipid and potentially other meta-
bolic networks. The tight coregulation between lipid species of
different classes, most notably between sphingolipids and glyc-
erophospholipids, suggested that part of the robustness of cells
to loss of certain membrane lipids may stem from the fact that
they are able to functionally compensate this by increasing other
lipids (Boumann et al., 2006). It is conceivable that the identified
coregulatory interactions are context-dependent, as observed
for genetic interactions and signaling networks (Bandyopadhyay
et al., 2010). Future comparisons with lipid coregulatory net-
works measured in different physiological contexts and with
measurements of additional lipid classes such as sterols will
allow to distinguish general properties from context-dependent
variation.
Sincemembrane lipids predominantly act in concert, and given
the strong coregulation of lipids observed, annotation of functions
for single lipid species in mammalian cells is challenging andmay
be uniquely amenable to systematic approaches such as the one
developedhere. The inference of lipid function, validated at the in-
dividual and global lipid level, revealed strikingly opposite func-
tions for individual ceramide species in TLR-driven inflammation(C) Lipid abundance plotted on the circular network for four patient fibroblast
abundance measurements is calculated and shown as in Figure 3I. Data are com
(D) IL-6 release phenotype predictions for each of the patient fibroblast sample
abundance. Red dashed line indicates p < 0.05. Colored areas indicate significant
(E) IL-6 release after stimulation with IMQ (25 mM) and LPS (1 mg/ml) as measur
unstimulated. Patient fibroblast bars are colored according to the predictions. Dat
± SD of four technical replicates. *p < 0.001.
(F) Summary of the LPS- and CpG-induced phenotype predictions for all fibrob
experiments. Blue and red areas indicate significant (p < 0.05) phenotype predic
See also Figure S5 and Table S3.(HannunandObeid, 2011), consistentwithprevious contradictory
reports on the role of ceramide in inflammation (Jo´zefowski et al.,
2010; Vandanmagsar et al., 2011). The functional annotations of
membrane lipids in the different TLR-related processes were
organized in a continuum on the circular lipid coregulatory
network, the implication of which requires further investigation.
The finding that the inflammatory state of perturbed cells could
be predicted based solely on this global functional annotation of
lipids indicates that the protein state of a cell mediating the in-
flammatory phenotype is strongly dependent on and intertwined
with the cellular lipid state. The concept of predicting functional
phenotypes based on different lipid states as outlined in this
work should be applicable to more membrane-dependent pro-
cesses such as cell division (Atilla-Gokcumen et al., 2014), pro-
liferation, apoptosis (Pettus et al., 2002), and autophagy (Singh
et al., 2009). Since many of the lipids measured here are present
in identical chemical form in different organisms (Guan et al.,
2010), the conservation of the identified lipid coregulation and
function is an exciting avenue for further research. The unbiased
functional annotation of lipids therefore advances lipidomics to
complement the genomic and proteomic characterization of
cells, expanding our toolset for the investigation and diagnosis
of complex diseases. Intriguingly, it may aid the informed design
of therapeutic interventions that modulate the cellular lipid state.
The framework developed here can identify the function of the
lipid landscape in additional biological settings, is scalable to
more and diverse perturbations and likely applicable to other
metabolites, invaluable for a systems-level understanding of
cellular physiology across organisms.
EXPERIMENTAL PROCEDURES
Human Fibroblasts
The following fibroblast samples were obtained from the NIGMS Human
Genetic Cell Repository at the Coriell Institute for Medical Research:
(GM02075, GM02315, GM05659). The ‘‘Cell line and DNA biobank from
patients affected by genetic diseases’’ (Istituto G. Gaslini), member of the
Telethon Network of Genetic Biobanks (project no. GTB12001) funded by
Telethon Italy, provided us with specimens of human fibroblasts.
Lipid Supplementation
All lipids were solubilized as previously described using ethanol/dodecane
(Wijesinghe et al., 2009). RAW264.7 cells were incubated for 30 min with indi-
cated lipid concentrations prior to LPS stimulation.
Lipidomics
Targeted lipidomics analysis was performed on an AB SCiex triple-quadrupole
mass spectrometer operating in positive and negativeMRMmode (BIOCRATES
Life Sciences AG, Innsbruck, Austria). Forty-threeCalibrators in seven levels andsamples. Significance of the clustering on the circular network for the lipid
bined of three independent experiments.
s are based on the correlation between lipid functional annotation and lipid
phenotype predictions (blue, increased IL-6 release; red, reduced IL-6 release).
ed by ELISA for patient fibroblasts and age-matched healthy controls. Mock:
a are representative of three independent experiments and presented as mean
last samples, colored according to the agreement between predictions and
tions as in (D).
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five internal standards (three of them were deuterated) were used to measure a
panel of glycerophospholipids and sphingolipids.
Lipidomics Data Normalization
The lipidomics results were normalized based on the sum of concentrations for
all lipid species measured in a single biological replicate. Values were next
averaged over the three biological replicates and log2 transformed against
the corresponding average concentrations measured in sh:GFP.
Network Clustering Significance
The significance of clustering of various features was calculated by comparing
the absolute difference of the given feature between a node and its nearest
neighbor as defined by the network, averaged over all nodes, with the distribu-
tion of over 10,000 repeats of the same calculation using randomly shuffled
feature values.
Membrane Fraction Enrichment Score
The lipid subcellular membrane fraction enrichment scores were calculated as
the Z score over the lipid concentrations measured for any one lipid species
over all the analyzed fractions (Andreyev et al., 2010).
Lipid Function Prediction
Functional predictions or associations for lipids were performed based on
Pearson’s linear correlation coefficients between the log2(FC) readouts of
the TLR-related functional assays and the log2(FC) in lipid levels, over the
nine shRNA cell lines.
General Statistics
P values were calculated with two-tailed t tests, unless otherwise indicated.
Correlation values given are Pearson’s linear correlation coefficients, unless
otherwise indicated.
See also the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
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